Reneo Income Before Tax vs Net Interest Income Analysis
RPHM Stock | USD 1.91 0.01 0.53% |
Reneo Pharmaceuticals financial indicator trend analysis is much more than just breaking down Reneo Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Reneo Pharmaceuticals is a good investment. Please check the relationship between Reneo Pharmaceuticals Income Before Tax and its Net Interest Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reneo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
Income Before Tax vs Net Interest Income
Income Before Tax vs Net Interest Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Reneo Pharmaceuticals Income Before Tax account and Net Interest Income. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Reneo Pharmaceuticals' Income Before Tax and Net Interest Income is 0.86. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Net Interest Income in the same time period over historical financial statements of Reneo Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Reneo Pharmaceuticals' Income Before Tax and Net Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of Reneo Pharmaceuticals are associated (or correlated) with its Net Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Interest Income has no effect on the direction of Income Before Tax i.e., Reneo Pharmaceuticals' Income Before Tax and Net Interest Income go up and down completely randomly.
Correlation Coefficient | 0.86 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Reneo Pharmaceuticals income statement and is an important metric when analyzing Reneo Pharmaceuticals profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most indicators from Reneo Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Reneo Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reneo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.As of the 21st of May 2024, Selling General Administrative is likely to drop to about 13.1 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 59.1 M
2020 | 2021 | 2023 | 2024 (projected) | Interest Income | 87K | 29K | 26.1K | 24.8K | Net Interest Income | 87K | 29K | 26.1K | 24.8K |
Reneo Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Reneo Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Reneo Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reneo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Reneo Stock analysis
When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Return On Assets (0.52) | Return On Equity (0.84) |
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.